Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Hematopoietic Recovery in AML
NCT07869342Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Oct 2026
- Primary completion
- Dec 2028
01
Overview
Randomised, open-label trial of acetylcysteine in acute myeloid leukemia (AML) (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Time to Platelet Recovery. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT07869342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07869342.